Mesoblast (MEOBF) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
Powered by 
Analysis
Mesoblast (MEOBF) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | -2.07% |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 5.31% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 4.29% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 19.95% |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 65.24% |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | 10.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.24% |
| Dec 31, 2025 | 4.84% |
| Jun 30, 2025 | -5.94% |
| Dec 31, 2024 | -25.92% |
| Jun 30, 2024 | -28.46% |
| Dec 31, 2023 | -28.75% |
| Jun 30, 2023 | -16.04% |
| Mar 31, 2023 | -8.93% |
| Dec 31, 2022 | 0.04% |
| Sep 30, 2022 | 22.23% |
| Jun 30, 2022 | 35.28% |
| Mar 31, 2022 | 39.57% |
| Dec 31, 2021 | 41.54% |
| Sep 30, 2021 | 39.36% |
| Jun 30, 2021 | 40.73% |
| Mar 31, 2021 | 33.26% |
| Dec 31, 2020 | 30.60% |
| Sep 30, 2020 | 11.93% |
| Jun 30, 2020 | 8.12% |
| Mar 31, 2020 | -3.00% |